PL378537A1 - Zastosowanie propionylo L-karnityny do otrzymywania leku do leczenia glaukomii - Google Patents

Zastosowanie propionylo L-karnityny do otrzymywania leku do leczenia glaukomii

Info

Publication number: PL378537A1
Authority: PL; Poland
Prior art keywords: carnitine; glaucoma; propionyl; medicament; preparation
Prior art date: 2002-10-01

Application number

PL378537A

Other languages

English (en)

Inventor

Menotti Calvani

Emilia Reda

Original Assignee

Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-01

Filing date

2003-09-23

Publication date

2006-05-02

2003-09-23 Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

2006-05-02 Publication of PL378537A1 publication Critical patent/PL378537A1/pl

Links

208000010412 Glaucoma Diseases 0.000 title 1
UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL378537A 2002-10-01 2003-09-23 Zastosowanie propionylo L-karnityny do otrzymywania leku do leczenia glaukomii PL378537A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000492A ITRM20020492A1 (it)	2002-10-01	2002-10-01	Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.

Publications (1)

Publication Number	Publication Date
PL378537A1 true PL378537A1 (pl)	2006-05-02

Family

ID=11456502

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL378537A PL378537A1 (pl)	2002-10-01	2003-09-23	Zastosowanie propionylo L-karnityny do otrzymywania leku do leczenia glaukomii

Country Status (8)

Country	Link
US (1)	US20060194874A1 (pl)
EP (1)	EP1545494A1 (pl)
AU (1)	AU2003274703A1 (pl)
CA (1)	CA2504015A1 (pl)
IT (1)	ITRM20020492A1 (pl)
MX (1)	MXPA05004465A (pl)
PL (1)	PL378537A1 (pl)
WO (1)	WO2004030666A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7512436B2 (en) *	2004-02-12	2009-03-31	The Regents Of The University Of Michigan	Method of evaluating metabolism of the eye
US8569367B2 (en)	2004-11-16	2013-10-29	Allergan, Inc.	Ophthalmic compositions and methods for treating eyes
US8299079B2 (en)	2009-05-22	2012-10-30	Kaufman Herbert E	Preparations and methods for ameliorating or reducing presbyopia
WO2010135731A1 (en) *	2009-05-22	2010-11-25	Kaufman Herbert E	Preparations and methods for ameliorating or reducing presbyopia
US9907826B2 (en)	2011-12-07	2018-03-06	Allergan, Inc.	Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9357912B2 (en) *	2013-09-09	2016-06-07	Yan Zhang	Apparatus and method for characterizing biomechanical properties of eye tissue
IT201900002441A1 (it) *	2019-02-21	2020-08-21	Nicola Pescosolido	Composto utile per il trattamento del glaucoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1224795B (it) *	1988-12-01	1990-10-24	Sigma Tau Ind Farmaceuti	Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
IT1290801B1 (it) *	1996-07-05	1998-12-11	Mendes Srl	Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
IT1288399B1 (it) *	1996-12-03	1998-09-22	Sigma Tau Ind Farmaceuti	Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi

2002
- 2002-10-01 IT IT000492A patent/ITRM20020492A1/it unknown
2003
- 2003-09-23 MX MXPA05004465A patent/MXPA05004465A/es not_active Application Discontinuation
- 2003-09-23 PL PL378537A patent/PL378537A1/pl unknown
- 2003-09-23 EP EP03758669A patent/EP1545494A1/en not_active Withdrawn
- 2003-09-23 WO PCT/IT2003/000566 patent/WO2004030666A1/en not_active Ceased
- 2003-09-23 AU AU2003274703A patent/AU2003274703A1/en not_active Abandoned
- 2003-09-23 CA CA002504015A patent/CA2504015A1/en not_active Abandoned
- 2003-09-23 US US10/537,057 patent/US20060194874A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MXPA05004465A (es)	2005-07-26
EP1545494A1 (en)	2005-06-29
ITRM20020492A1 (it)	2004-04-02
US20060194874A1 (en)	2006-08-31
ITRM20020492A0 (it)	2002-10-01
AU2003274703A1 (en)	2004-04-23
CA2504015A1 (en)	2004-04-15
WO2004030666A1 (en)	2004-04-15

Similar Documents

Publication	Publication Date	Title
AU2003279338A1 (en)	2004-05-25	Phenethanolamine derivatives for the treatment of respiratory diseases
PL377122A1 (pl)	2006-01-23	Pochodne fenetanoloaminy do leczenia chorób układu oddechowego
IL213806A0 (en)	2011-07-31	Use of derivatives of n-phenylpiperazin-1-yl-acetamide for the preparation of a pharmaceutical compositions for treatment of diabetes related conditions
AU2003291992A1 (en)	2004-05-25	Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003210428A1 (en)	2003-09-09	Phenethanolamine derivatives for treatment of respiratory diseases
IL160595A0 (en)	2004-07-25	Phenethanolamine derivatives for treatment of respiratory diseases
MXPA03007262A (es)	2003-12-08	Derivados de fenetanolamina para el tratamiento de enfermedades respiratorias.
AU2002366355A1 (en)	2003-06-30	SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
PL375964A1 (pl)	2005-12-12	Zastosowanie pochodnych indolilu do wytwarzania leku do leczenia kataru siennego
TWI345975B (en)	2011-08-01	Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
PL1670482T5 (pl)	2022-10-03	Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
IL167187A (en)	2010-12-30	Composition comprising modafinil, said composition for use as a medicament and use of said composition for the preparation of medicament
AU2002338303A1 (en)	2002-10-28	Therapeutic compositions for the treatment of a respiratory tract disease
PL378537A1 (pl)	2006-05-02	Zastosowanie propionylo L-karnityny do otrzymywania leku do leczenia glaukomii
IL162853A0 (en)	2005-11-20	The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
AU2002231811A1 (en)	2003-02-20	Use of flumazenil to produce a medicament for the treatment of cocaine dependency
PL375564A1 (pl)	2005-11-28	Podstawione 5-chroman-5-ylo-etyloaminy i ich zastosowanie do leczenia jaskry
EP1581209A4 (en)	2009-03-11	NEW BENZOPYRAN ANALOGUE AND ITS USE FOR THE TREATMENT OF GLAUKOM
AU2003209542A8 (en)	2003-09-22	Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
GB0209254D0 (en)	2002-06-05	Preparation for the relief of disease
GB0306088D0 (en)	2003-04-23	Process for the preparation of a cosmetic active
AU2002311141A1 (en)	2003-07-15	The use of hydrochloric acid in the preparation of a medicament for the treatment of tumour
GB0212790D0 (en)	2002-07-10	Medicament for the treatment of diabetes
HUP0401294A3 (en)	2008-04-28	Use of acetyl l-carnitine for the preparation of a pharmaceutical composition for the preventive therapy for pain
GB0306081D0 (en)	2003-04-23	Process for the preparation of a cosmetic active

Legal Events

Date	Code	Title	Description
2009-01-30	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)